This assay has high sensitivity and excellent specificity for detection of Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa).No significant cross-reactivity or interference between Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) and analogues was observed.
Matrices listed below were spiked with certain level ofAnti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 93-101 | 96 |
EDTA plasma(n=5) | 81-101 | 89 |
heparin plasma(n=5) | 97-105 | 101 |
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) were tested on 3 different plates, 8 replicates in each plate. CV(%) = SD/meanX100 Intra-Assay: CV<10%>10%>Inter-Assay: CV<12%>12%>
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 80-93% | 80-102% | 80-101% | 78-90% |
EDTA plasma(n=5) | 96-105% | 83-93% | 79-92% | 88-97% |
heparin plasma(n=5) | 89-103% | 80-90% | 87-95% | 96-105% |
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
1. Prepare all reagents, samples and standards;2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;4. Aspirate and wash 5 times;5. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;6. Add 50µL Stop Solution. Read at 450nm immediately.
The microtiter plate provided in this kit has been pre-coated with an antigen. Standards or samples are then added to the appropriate microtiter plate wells with a Horseradish Peroxidase (HRP)-conjugated secondary antibody. After TMB substrate solution is added, those wells that contain Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
ELISA / CLIA Experiment Service
Single-component Reagents of Assay KitLysis Buffer Specific for ELISA / CLIAQuality Control of ELISA / CLIADisease Model Customized ServiceTGFB1 Activation ReagentReal Time PCR Experimental Service
Catalog No. | Organism species: Homo sapiens (Human) | Applications (RESEARCH USE ONLY!) |
APA133Hu01 | Active Tumor Necrosis Factor Alpha (TNFa) | Cell culture; Activity Assays. |
RPA133Hu01 | Recombinant Tumor Necrosis Factor Alpha (TNFa) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA133Hu01 | Polyclonal Antibody to Tumor Necrosis Factor Alpha (TNFa) | WB; IHC; ICC; IP. |
LAA133Hu81 | FITC-Linked Polyclonal Antibody to Tumor Necrosis Factor Alpha (TNFa) | WB; IHC; ICC; IF. |
LAA133Hu71 | Biotin-Linked Polyclonal Antibody to Tumor Necrosis Factor Alpha (TNFa) | WB; IHC; ICC. |
MAA133Hu22 | Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa) | WB; IHC; ICC; IP. |
MAA133Hu21 | Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa) | WB; IHC; ICC; IP. |
LAA133Hu72 | Biotin-Linked Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa) | WB; IHC; ICC. |
MEA133Hu | Mini Samples ELISA Kit for Tumor Necrosis Factor Alpha (TNFa) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEA133Hu | ELISA Kit for Tumor Necrosis Factor Alpha (TNFa) | Enzyme-linked immunosorbent assay for Antigen Detection. |
HEA133Hu | High Sensitive ELISA Kit for Tumor Necrosis Factor Alpha (TNFa) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AEA133Hu | ELISA Kit for Anti-Tumor Necrosis Factor Alpha Antibody (Anti-TNFa) | Enzyme-linked immunosorbent assay for Antibody Detection. |
SCA133Hu | CLIA Kit for Tumor Necrosis Factor Alpha (TNFa) | Chemiluminescent immunoassay for Antigen Detection. |
PSA133Hu01 | Antibody Pair for Tumor Necrosis Factor Alpha (TNFa) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA133Hu01 | ELISA Kit DIY Materials for Tumor Necrosis Factor Alpha (TNFa) | Main materials for "Do It(ELISA Kit) Yourself" |
在20mM Tris,150mM NaCl(pH8.0)中复溶至0.1-1.0 mg / mL的浓度。不要涡旋。
避免重复冷冻/解冻循环。在2-8°C下保存一个月。分装并在-80°C下存储12个月。
热稳定性由损失率描述。损失率通过加速热降解试验确定,即将蛋白质在37°C下孵育48h,没有观察到明显的降解和沉淀。在适当的存储条件下,有效期内的丢失率小于5%。